What can psychedelics teach us about the sense of self?
Researchers used a psychedelic as a tool to advance understanding of brain activity for the human sense of self.
2025-11-24
(Press-News.org) When people use a psychedelic called dimethyltryptamine (DMT), they experience a temporary loss of their sense of self. DMT interacts with a frequency of brain activity associated with self-referential processes (alpha waves), but it’s unclear how this activity relates to self-awareness. Christopher Timmerman, at University College London, and Marco Aqil, currently at the University of Miami, are among researchers who used DMT as a tool to explore the relationship between alpha waves and self-awareness.
As reported in their JNeurosci paper, the researchers discovered that DMT interacts with alpha waves in a way that is associated with stronger ratings of loss of the sense of self, sometimes termed ego death. These activity changes were related to what is termed “criticality.” Elaborates Timmerman, “The way the brain operates between chaos and order allows for normal brain function. Criticality refers to a brain state balanced between chaos and order that helps us predict things about the environment, the way we change or adapt to it, and our self-awareness.”
Furthermore, the researchers found that this shift away from criticality was a dampening or quieting of alpha waves. Describing what this might mean, says Aqil, “We rely on past narratives and future predictions to have a coherent sense of self. In a DMT experience, people do not have a stream of consciousness over a period of time—everything takes place in the present moment. This shift in criticality signatures in the alpha frequency [during a DMT experience likely reveals how] the time-extended component of the sense of self is weakened.”
Both Timmerman and Aqil emphasize their work supports the idea that psychedelics may be a powerful tool for unraveling the neurological basis of human consciousness.
###
Please contact media@sfn.org for full-text PDF.
About JNeurosci
JNeurosci was launched in 1981 as a means to communicate the findings of the highest quality neuroscience research to the growing field. Today, the journal remains committed to publishing cutting-edge neuroscience that will have an immediate and lasting scientific impact, while responding to authors' changing publishing needs, representing breadth of the field and diversity in authorship.
About The Society for Neuroscience
The Society for Neuroscience is the world's largest organization of scientists and physicians devoted to understanding the brain and nervous system. The nonprofit organization, founded in 1969, now has nearly 35,000 members in more than 95 countries.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-11-24
Human emotional interaction relies heavily on CT afferents—unmyelinated nerves in hairy skin that convert gentle tactile stimuli into affective states. For robots to engage in similar empathetic communication, existing tactile sensing technologies fall short: most rely on segregated "sensation-transmission-processing" modules, which cause latency accumulation and high energy consumption due to repeated analog-to-digital conversion. "Current neuromorphic devices for touch either lack low-threshold sensitivity or separate ...
2025-11-24
**EMBARGOED FOR RELEASE UNTIL NOV. 24 AT 12 NOON**
Researchers at Johns Hopkins Medicine say they have used a “zap-and-freeze” technology to watch hard-to-see brain cell communications in living brain tissue from mice and humans.
Findings from the new experiments, supported by the National Institutes of Health and published Nov. 24 in Neuron, could potentially help scientists find the root causes of nonheritable forms of Parkinson’s disease, the researchers say.
Sporadic cases of Parkinson’s disease account for most ...
2025-11-24
COLUMBUS, Ohio – Using a prebiotic to influence bacterial activity in the gut after a traumatic brain injury may help reduce impulsive behavior, one of the common symptoms to follow a moderate blow to the head, a new study in rats suggests.
Following up on previous work showing a connection between negative changes to gut bacteria after a traumatic brain injury (TBI) and poor decision making, researchers at The Ohio State University are now exploring whether the gut problems may actually cause some long-term symptoms.
They found that adding the prebiotic galacto-oligosaccharide (GOS) to rat diets before and after ...
2025-11-24
About The Study: In a cohort composed primarily of women with obesity, glucagon-like peptide-1 receptor agonist (GLP-1RA) use with subsequent pre-pregnancy or early pregnancy discontinuation was associated with more gestational weight gain and a higher risk of preterm delivery, gestational diabetes, and hypertensive disorders of pregnancy.
Corresponding Authors: To contact the corresponding authors, email Jacqueline Maya, MD, (jmaya@mgh.harvard.edu) and Camille E. Powe, MD, (camille.powe@mgh.harvard.edu).
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.20951)
Editor’s Note: Please ...
2025-11-24
About The Study: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are increasingly used for postpartum weight loss since the introduction of semaglutide for weight loss in late 2022. Most users were overweight prior to pregnancy and only 23% had a documented diabetes diagnosis, suggesting that the primary indication for use was weight reduction.
Corresponding Author: To contact the corresponding author, Mette Bliddal, PhD, email mbliddal@health.sdu.dk.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2025.20947)
Editor’s Note: Please see the article for additional information, including ...
2025-11-24
In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 drugs. The findings are published in JAMA.
“The use of glucagon-like peptide-1 receptor agonists—or GLP-1RAs—has increased dramatically, but recommendations suggest their discontinuation before pregnancy ...
2025-11-24
New research reveals that people with untreated obstructive sleep apnea have a higher risk of developing Parkinson’s disease. However, they can significantly reduce the risk by improving the quality of their sleep by using continuous positive airway pressure, or CPAP.
The study, which published today in the journal JAMA Neurology, examined electronic health records covering more than 11 million U.S. military veterans who received care through the Department of Veterans Affairs between 1999 and 2022.
The research was led by Oregon Health & Science University ...
2025-11-24
About The Study: This cohort study found that the prevalence of avoidant/restrictive food intake in the general pediatric population was substantial, and affected children had an associated elevated risk of developmental difficulties across multiple domains. The findings suggest a need for broad support interventions and advance understanding of the genetic underpinnings of avoidant/restrictive food intake.
Corresponding Author: To contact the corresponding author, Ludvig Daae Bjorndal, PhD, email l.d.bjorndal@psykologi.uio.no.
To ...
2025-11-24
About The Study: In this post hoc analysis of the SURMOUNT-4 trial, among participants with obesity who achieved weight reduction with 36-week tirzepatide (a glucagon-like peptide-1 receptor agonist) treatment, withdrawing tirzepatide led to 25% or greater weight regain in most participants within 1 year and was associated with a greater reversal of their initial cardiometabolic parameter improvements compared with those who maintained weight reduction. These findings underscore the importance of continued obesity treatment.
Corresponding Author: To contact the corresponding author, Clare J. Lee, MD, MHS, ...
2025-11-24
About The Study: This cross-sectional study of the Global Burden of Disease 2021 study data found that, among the U.S. population of 332.7 million, disorders affecting nervous system health impacted 180.3 million U.S. individuals and were the top cause of disability. Conditions with the greatest collective disability were stroke, Alzheimer disease and
other dementias, diabetic neuropathy, and migraine. The U.S. should prioritize efforts to combat these conditions with development and implementation of new and effective prevention strategies, therapeutics, and focused rehabilitation.
Corresponding ...
LAST 30 PRESS RELEASES:
[Press-News.org] What can psychedelics teach us about the sense of self?
Researchers used a psychedelic as a tool to advance understanding of brain activity for the human sense of self.